JPRN-UMIN000011468招募中未知
Effects of LOTRIGA in chronic heart failure patients with hyperlipidemia:a prospective randomized,open-label,parallel group comparison study - Effects of LOTRIGA in chronic heart failure patients with hyperlipidemia(EPA/DHA study)
Aichi Medical University,Department of Cardiology0 个研究点目标入组 60 人开始时间: 2013年8月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.patients who are planned PCI or CABG 2.patients who have myocardial ischemia 3.unstable patient due to non-cardiac disease 4.pregnant woman 5.patients who are judged to be inappropriate to this study
研究者
相似试验
进行中（未招募）
1 期
iraglutide in chronic heart failure. A randomised, double-blind, placebo-controlled study of the effect of LIraglutide on the left VEntricular function in patients with chronic heart failure with and without type 2 diabetes (The LIVE-study).EUCTR2011-002468-26-DKAllan Flyvbjerg
招募中
2 期
Ertugliflozin in Chronic Heart FailureHeart FailureNCT04438213Yale University60
已完成
Unknown
Efficacy of SGLT2 inhibitors in heart failure patients with preserved left ventricular functioHeart failureJPRN-UMIN000053988ihon University School of Medicine, Division of Cardiology, Department of Medicine35
已完成
不适用
Efficacy of Tolvaptan in heart failure patients with preserved Ejection fraction: multicenter, RaNdomized, open-label triAL (ETERNAL)Heart Failure with Preserved Ejection Fraction (HFPEF)JPRN-UMIN000011012agoya University Graduate School of Medicine, Department of Cardiology100
进行中（未招募）
1 期
Empagliflozin in heart failure patients with reduced ejection fraction:A randomized clinical trial (Empire HF)EUCTR2017-001341-27-DKMorten Schou190